We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novo Nordisk’s Oral Semaglutide Sees 15 Percent Weight Loss and Better Diabetes Control
Novo Nordisk’s Oral Semaglutide Sees 15 Percent Weight Loss and Better Diabetes Control
Multiple clinical trial results from two manufacturers posted in the past several days in The Lancet show high levels of success of both weight loss in obese adults and in control of type 2 diabetes through weight loss.
